Sanofi Logo

Sanofi

Global biopharma firm researching, developing & marketing prescription medicines & vaccines.

SAN | PA

Overview

Corporate Details

ISIN(s):
FR0000120578 (+39 more)
LEI:
549300E9PC51EN656011
Country:
France
Address:
46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sanofi is a global biopharmaceutical company engaged in the research, development, manufacturing, and marketing of therapeutic solutions, primarily prescription medicines and vaccines. The company leverages science and digital technologies, including AI, to discover and deliver treatments across various healthcare areas. With a worldwide presence, Sanofi operates through multiple divisions and specialized R&D-focused subsidiaries like Ablynx, Kymab, and Principia to advance its pipeline. It aims to transform the practice of medicine and improve public health by providing innovative healthcare products to millions of people globally. The company also manufactures and supplies active pharmaceutical ingredients through its Sanofi Active Ingredient Solutions arm.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-06 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 6.4 MB
2025-10-06 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 6.3 MB
2025-09-29 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.4 MB
2025-09-29 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.4 MB
2025-09-22 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.4 MB
2025-09-22 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.4 MB
2025-09-15 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.6 MB
2025-09-15 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 444.0 KB
2025-09-12 18:30
Declaration of Voting Results & Voting Rights Announcements
Sanofi: Information concerning the total number of voting rights and shares - A…
English 136.1 KB
2025-09-12 18:30
Declaration of Voting Results & Voting Rights Announcements
Sanofi: Informations relatives au nombre de droits de vote et d'actions - AOUT …
French 112.1 KB
2025-09-02 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.9 MB
2025-09-02 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.9 MB
2025-08-25 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.4 MB
2025-08-18 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.7 MB
2025-08-18 18:30
Declaration of Voting Results & Voting Rights Announcements
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juill…
French 121.9 KB

Automate Your Workflow. Get a real-time feed of all Sanofi filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Sanofi via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-05-02 N/A Other Buy 71,423 N/A
2024-04-26 N/A Other Buy 1,000 91,380.00 EUR
2023-06-09 N/A Other Buy 9 856.04 EUR
2023-05-02 N/A Other Buy 65,205 6,364,008.00 EUR
2023-05-02 N/A Other Buy 500 48,835.00 EUR

Peer Companies

Company Country Ticker View
ChoA Pharmaceutical Co., LTD. Logo
Global manufacturer of OTC medicines and health supplements distributed through pharmacies.
South Korea 034940
CHUGAI PHARMACEUTICAL CO., LTD. Logo
An R&D pharma leader in Japan creating innovative drugs via antibody engineering technology.
Japan 4519
Cinclus Pharma Holding AB Logo
Clinical-stage pharma developing a next-gen P-CAB drug for severe GERD patients.
Sweden CINPHA
Circio Holding ASA Logo
Developing circular RNA vector tech and immunotherapies for gene and cell therapies.
Norway CRNA
CJ Bioscience Logo
Develops microbiome therapeutics for oncology & IBD using an AI drug discovery platform.
South Korea 311690
CKD Bio Corp. Logo
Develops and manufactures probiotics & APIs using fermentation, also offering cGMP CMO services.
South Korea 063160
CMG Pharmaceutical Co., Ltd. Logo
Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.
South Korea 058820
co.don AG Logo
Develops personalized cartilage cell transplants for minimally invasive joint repair.
Germany CNW
Compugen Ltd. Logo
Uses AI to discover and develop novel antibody immunotherapies for hard-to-treat cancers.
Israel CGEN
CORESTEMCHEMON Inc. Logo
Develops stem cell therapies & provides preclinical CRO services to pharma & biotech.
South Korea 166480

Talk to a Data Expert

Have a question? We'll get back to you promptly.